InvestorsHub Logo

seasonedwell

11/08/16 8:46 PM

#1920 RE: Rogerthat1 #1919

For me, not a real concern....

Seems, to me, many are focusing on the wrong end of the equation.

How much more could financing dilute even if we have to go another year (20% 25%)and it worse case scenario. That's if financing is done buy Roth at current terms which I suspect is invalid assumption. Should be higher and could even be done by big pharma with just an equity investment.

I'm pretty sure the asset is worth several hundred million now and that will double/triple as we go into next year. VRX will drive Addyi sales/market exposure upward starting January. That will drive the value of our hidden gem, much much higher. It's very likely a customer for Addyi is 3 customers for PTN. 200 million buys a strong market push, one that encompasses a Super bowl ad.

Most likely a partnership/buyout will happen before end of the year making the aforementioned moot.

I'm here in at near very bottom and it's certainly much cheaper to be in than out. A buyout would cost me everything if I'm not in.

Rogerthat1

12/01/16 1:03 PM

#2139 RE: Rogerthat1 #1919

Glad I stayed away from this one. Longer term might work out but I made nice coin on the P3 here and glad I didn't marry the stock. $PTN